Sun Pharma reported consolidated revenue growth of 13.9% for Q2 FY27, led by its Technology division, which contributed 15.4% of the total. Operating margin held at 3.5%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.
A new long-term agreement with Mahindra Group anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.
The numbers
Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2030, and disclosed that 15.4% of electricity at its main sites now comes from renewable sources under long-term contracts.
Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.
By the numbers
Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $311 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.
“Visibility is worth more than growth. We can plan investments when we can see 14 months ahead.”
Expansion and capital allocation
Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 15.4% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.
Source: IGEN Intelligence analysis of un comtrade data. Illustrative mock data.
Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.
| Segment | Revenue | YoY | Margin |
|---|---|---|---|
| Technology (core) | $51M | +2.1% | 25.4% |
| Exports | $165M | +8.3% | 14.9% |
| Domestic retail | $84M | +6.8% | 15.9% |
| Services | $71M | +1.7% | 9.7% |
| Other | $301M | +7.8% | 25% |
Customers, contracts and exports
Capital expenditure guidance was raised to $6 billion for the fiscal year, from $311 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 3.5% more output without additional land.
Timeline of key events
- Results announced
Revenue up 13.9%; margin steady at 3.5%.
- Capex raised
Guidance moves to $6 billion to fund automation and debottlenecking.
- Supply pact signed
Multi-year agreement with Mahindra Group at index-linked pricing.
- Groundbreaking
Construction at the new facility near Hazira begins.
- First production
Targeted within 20 months of groundbreaking.
On the post-results call, management said the order book now stands at $6 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in United Kingdom and Germany. The chief financial officer described visibility as the best in five years.
Expert commentary
“The pact is not just volume; it is a joint roadmap for higher-value products.”
“What matters now is execution. The announcements are in place; the next two quarters will show who can deliver.”
“For Technology, the margin of safety is in diversification: two markets, two gateways and two sources of finance.”
Risks and analyst view
Export performance was a bright spot. Shipments to United Kingdom rose 13.9%, helped by certification wins and shorter lead times from Hazira. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.
What it means for you
Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.
Expansion will lift procurement; engage early on qualification for the new lines.
Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.
About 1,200 direct roles and a technician academy are planned near Hazira; applications open with the state skills portal.
Companies and leaders in this story
Frequently asked questions
Sources
- UN Comtrade: Bilateral trade flows by HS code
- Ministry-level press releases: Scheme guidelines and cabinet decisions
- Port authority statistics: Container volumes, dwell times and berth productivity
- Company filings and earnings calls: Disclosures on order books and capex
Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.
